Faculty profile
James Davie
Back to facultyThis profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Manitoba directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Proceedings of the Canadian Society for Molecular Biosciences (CSMB) 2024 Conference - Gene Regulation: From Cells to Systems.
Biochemistry and cell biology = Biochimie et biologie cellulaire · 2025 · senior author
Latest funding
- $172,000
Transcriptionally active chromosomal domains
NSERC · 2023 · Principal investigator
- $990,675
Investigating the molecular and cellular abnormalities of the brain in Rett Syndrome
CIHR · 2022 · Co-investigator
- $100,000
Investigating the molecular and cellular abnormalities of the brain in Rett Syndrome
CIHR · 2022 · Co-investigator
1 publications.
Proceedings of the Canadian Society for Molecular Biosciences (CSMB) 2024 Conference - Gene Regulation: From Cells to Systems.
Rastegar M, Wieden H, Davie JR
Transcriptionally active chromosomal domains
Principal investigators: Davie, James
Keywords: Chicken erythrocytes; Chromatin-associated proteins; Chromatin domains; Chromatin fractionation; Chromatin immunoprecipitation assay; Chromatin remodeling; Gene expression; Histone modifications; Imaging; Transcriptionally active chromatin
Investigating the molecular and cellular abnormalities of the brain in Rett Syndrome
Principal investigators: Rastegar, Mojgan
Keywords: Childhood Neurodevelopmental Disorders; Dna Methylation; Epigenetics; Genetics; Human Brain Tissues; Mechanism Of Disease; Metabolic Drugs; Pre-Clinical Studies; Rett Syndrome; Transgenic Mice
Investigating the molecular and cellular abnormalities of the brain in Rett Syndrome
Principal investigators: Rastegar, Mojgan
Keywords: Childhood Neurodevelopmental Disorders; Dna Methylation; Genetics; Human Brain Tissues; Mechanism Of Disease; Mecp2; Metabolic Drugs; Pre-Clinical Studies; Rett Syndrome; Transgenic Mice
Determine how the interaction between SARS-CoV-2 spike protein and angiotensin-converting enzyme 2 (ACE2) affect viral spread and the severity of COVID-19 outcomes.
Principal investigators: Su, Ruey-Chyi; Davie, James R
Keywords: Ace2 (Angiotensin-Converting Enzyme 2); Antiviral Response; Gene Regulation; Inflammation; Primary Human Cells; Sars-Cov-2 Spike Protein Variants
Targeted inhibition of DNA methyltransferase
Principal investigators: Lakowski, Ted
Keywords: Drug discovery Medicinal chemistry Biologic drugs Epigenetics Mass Spectrometry Gene expression Nanoparticle drug delivery DNA methylation Aptamers Gene and molecular therapy
Artificial Intelligence based adaptive and interpretable models for analyzing multi-track epigenomic sequential data
Principal investigators: Ashraf, Ahmed
Keywords: 3d Chromatin; 3d Genome; Artificial Intelligence; Deep Learning; Epigenetics; Machine Learning; Sequence Modeling
Oligonucleotide-bioconjugate mediated repression of the HOXA9 gene to treat mixed-lineage leukemia
Principal investigators: Lakowski, Ted M
Keywords: Drug Bio-Conjugation; Drug Development; Drug Discovery; Drug Targeting; Epigenetics; Histone Lysine Methyltransferase; Liquid Chromatography Tandem Mass Spectrometry; Post Translational Modifications
Histone arginine methylation and transcriptionally active chromosomal domains
Principal investigators: Davie, James
Protein arginine methyltransferases and transcriptionally active chromosomal domains
Principal investigators: Davie, James
The Developmental Origins of Obesity and Obesity-related Complications in Children
Principal investigators: Dolinsky, Vernon W; Davie, James R; Kobor, Michael S; Shen, Garry X; Wicklow, Brandy A
Keywords: Children'S Health; Diabetes; Epigenetics; Gene Expression; Maternal Health; Metabolism; Obesity; Pregnancy
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.